Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia.

Linger RM, DeRyckere D, Brand?o L, Sawczyn KK, Jacobsen KM, Liang X, Keating AK, Graham DK. Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia. Blood. 2009 Sep 24; 114(13):2678-87.

View in: PubMed

subject areas

Animals
Antineoplastic Agents
Cell Survival
Child
c-Mer Tyrosine Kinase
Drug Delivery Systems
Gene Expression Regulation, Leukemic
Gene Knockdown Techniques
Humans
Mice
Mice, Inbred NOD
Mice, SCID
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Proto-Oncogene Proteins
Receptor Protein-Tyrosine Kinases
RNA, Small Interfering
Tumor Cells, Cultured
Xenograft Model Antitumor Assays

authors with profiles

Xiayuan Liang